All companies › CYTK

CYTK · CYTOKINETICS INC

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells13
Research cases0
Last filing2026-10-20

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-31 — Blum Robert I · sold 7,500 @ $70.24 2026-08-31 — Callos Andrew · sold 10,000 @ $70.24 2026-09-01 — PARSHALL B LYNNE · sold 5,000 @ $71.48 2026-09-08 — Malik Fady Ibraham · sold 3,500 @ $75.46 2026-09-11 — Landry Robert E · sold 1,000 @ $74.66 2026-09-14 — Blum Robert I · sold 7,500 @ $73.44 2026-09-15 — Blum Robert I · sold 97,926 @ $69.33 2026-09-15 — Landry Robert E · sold 1,000 @ $72.13 2026-09-22 — Malik Fady Ibraham · sold 3,500 @ $68.29 2026-09-28 — Blum Robert I · sold 7,500 @ $65.46 2026-10-06 — Malik Fady Ibraham · sold 3,500 @ $61.38 2026-10-12 — Blum Robert I · sold 7,500 @ $62.88 2026-10-20 — Malik Fady Ibraham · sold 3,500 @ $64.01
2026-08-312026-10-20

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Blum Robert I President & CEO, Director
Malik Fady Ibraham EVP Research & Development
Landry Robert E Director
Callos Andrew EVP, Chief Commercial Officer
PARSHALL B LYNNE Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $CYTK is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-20', 'insider_name': 'Malik Fady Ibraham', 'insider_title': 'EVP Research & Development', 'transaction_type': 'Open-market sell', 'shares': 3500.0, 'price': 64.01, 'value': 224035.0, 'is_buy': False}, {'transaction_date': '2026-10-12', 'insider_name': 'Blum Robert I', 'insider_title': 'President & CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 62.88, 'value': 471600.0, 'is_buy': False}, {'transaction_date': '2026-10-06', 'insider_name': 'Malik Fady Ibraham', 'insider_title': 'EVP Research & Development', 'transaction_type': 'Open-market sell', 'shares': 3500.0, 'price': 61.38, 'value': 214830.0, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Blum Robert I', 'insider_title': 'President & CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 65.46, 'value': 490950.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Malik Fady Ibraham', 'insider_title': 'EVP Research & Development', 'transaction_type': 'Open-market sell', 'shares': 3500.0, 'price': 68.29, 'value': 239015.0, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Blum Robert I', 'insider_title': 'President & CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 97926.0, 'price': 69.33, 'value': 6789209.58, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Landry Robert E', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 72.13, 'value': 72130.0, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Blum Robert I', 'insider_title': 'President & CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 73.44, 'value': 550800.0, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Landry Robert E', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 74.66, 'value': 74660.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Malik Fady Ibraham', 'insider_title': 'EVP Research & Development', 'transaction_type': 'Open-market sell', 'shares': 3500.0, 'price': 75.46, 'value': 264110.0, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'PARSHALL B LYNNE', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 5000.0, 'price': 71.48, 'value': 357400.0, 'is_buy': False}, {'transaction_date': '2026-08-31', 'insider_name': 'Blum Robert I', 'insider_title': 'President & CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 7500.0, 'price': 70.24, 'value': 526800.0, 'is_buy': False}, {'transaction_date': '2026-08-31', 'insider_name': 'Callos Andrew', 'insider_title': 'EVP, Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 10000.0, 'price': 70.24, 'value': 702400.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for CYTK today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.